Mid Day14 小时
Mira Road: Mother, preterm baby survive rare life-threatening disorder in high-risk pregnancy
The pregnant woman had delivered a healthy preterm baby weighing 1.2 kg following an emergency cesarean section and an ...
Pharmaceutical Technology14 天
YTS-109 by Bristar Immunotech Biotechnology for Polymyositis: Likelihood of Approval
YTS-109 is under clinical development by Bristar Immunotech Biotechnology and currently in Phase I for Polymyositis.
Pharmaceutical Technology14 天
YTS-109 by Bristar Immunotech Biotechnology for Dermatomyositis: Likelihood of Approval
YTS-109 is under clinical development by Bristar Immunotech Biotechnology and currently in Phase I for Dermatomyositis.